Mohan HK, Routledge T, Cane P, Livieratos L, Ballinger JR, Peters AM. Does the Clearance of Inhaled 99mTc-Sestamibi Correlate with Multidrug Resistance Protein 1 Expression in the Human Lung?
Radiology. 2016 Mar 7:151389. (Epub ahead of print)
Agrawal K, Weaver J, Ul-Hassan F, Jeannon JP, Simo R, Carroll P, Hubbard JG, Chandra A, Mohan HK
Incidence and Significance of Incidental Focal Thyroid Uptake on 18F-FDG PET Study in a Large Patient Cohort: Retrospective Single-Centre Experience in the United Kingdom. Eur Thyroid J 2015;4:115-122
Malavika Nathan, Fahim-ul Hassan, Hosahalli K Mohan: Advances in imaging in differentiated thyroid cancer: focus on SPECT/CT and PET/CT: Expert Review of Endocrinology and Metabolism, July 2011, Vol. 6, No. 4, Pages 599-616.
Helyar V, Mohan HK, Barwick T, Livieratos L, Gnanasegaran G, Clarke SE, Fogelman I. The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate. Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):706-13. Epub 2009 Dec 17.
HK Mohan, KA Miles. Cost-Effectiveness of 99mTc-Sestamibi in Predicting Response to Chemotherapy in Patients with Lung Cancer: Systematic Review and Meta-Analysis. J Nucl Med. 2009 Mar;50(3):376-81